Paper Details

  1. Home
  2. Paper Details

Post marketing new adverse effects of oral therapies in multiple sclerosis: A systematic review.

Author: AtaeiSara, EsfahaniMaryam Etminani, JenabiEnsiyeh, SahraianMohammad Ali, SalehiAmir Mohammad

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

While medications called disease-modifying drugs (DMDs) are used to manage multiple sclerosis (MS), there isn't enough information about the side effects that may occur after they are released to the market. This review aimed to identify the DMDs used for MS and to highlight the need for more research on their safety profile.
Paper Details　
Original Abstract of the Article :
There is a lack of safety information about the post-marketing adverse effects of several disease-modifying drugs (DMDs) used to control multiple sclerosis (MS). Investigating the post-marketing side effects is required to manifest the safety of the appropriate therapy. Therefore, the present system...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.msard.2022.104157

データ提供：米国国立医学図書館（NLM）

Investigating Post-Marketing Adverse Effects of Oral Therapies for Multiple Sclerosis

This [systematic review] focuses on the [safety of disease-modifying drugs (DMDs)] used to [control multiple sclerosis (MS)]. The authors aim to identify [post-marketing adverse effects] of [oral therapies] for [MS] to ensure the [safety of appropriate treatment]. The review highlights the need for [further research] to [better understand] the [long-term effects] of [DMDs] and [optimize patient safety].

The Importance of Post-Marketing Surveillance

The study emphasizes the [importance of ongoing monitoring] of [DMDs] to identify [potential adverse effects] that may not have been detected during [clinical trials]. This is particularly important for [chronic conditions] like [MS] where patients may be on [long-term treatment] with [DMDs].

Ensuring Patient Safety and Optimizing Treatment

The review highlights the [need for vigilance] in [monitoring the safety of DMDs] to ensure the [best possible outcomes] for [people living with MS]. By [identifying and managing] [potential adverse effects], we can [optimize treatment effectiveness] and [improve patient safety].

Dr.Camel's Conclusion

As a camel navigates the ever-changing desert landscape, [MS] research requires [continuous adaptation]. This [systematic review] highlights the [importance of ongoing surveillance] to ensure the [safety and effectiveness] of [DMDs] used to treat [MS].

Date :
  1. Date Completed 2022-12-14
  2. Date Revised 2022-12-22
Further Info :

Pubmed ID

36122472

DOI: Digital Object Identifier

10.1016/j.msard.2022.104157

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.